Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long‐term results: 合并心房颤动的糖尿病患者通过左心耳封堵术 …
…, B Kapelak, D Lakkireddy, K Bartus - Journal of …, 2019 - Wiley Online Library
… % of patients with AF, OAC is contraindicated.7 Moreover, DM patients taking non-vitamin K
oral anticoagulants … The longer the duration of DM in patients with AF, the greater the risk of …
oral anticoagulants … The longer the duration of DM in patients with AF, the greater the risk of …
探討新型口服抗凝血劑用於心房顫動病人的有效性及安全性
MC Lee - 高雄醫學大學藥學系碩士在職專班學位論文, 2018 - airitilibrary.com
… Background Atrial fibrillation (AF) patients have a higher risk … Non-vitamin K antagonist
oral anticoagulants (NOACs) had … However, since some studies indicated that Asian people …
oral anticoagulants (NOACs) had … However, since some studies indicated that Asian people …
心房顫動合併冠狀動脈疾病抗血栓治療
雷青熒， 蔡慈貞， 溫明賢 - 臺灣臨床藥學雜誌, 2019 - airitilibrary.com
… TAT duration will be provided in two ongoing non-vitamin K antagonist oral anticoagulant
(NOAC) in AF trials. Key words: Atrial Fibrillation, Percutaneous Coronary Intervention, Triple …
(NOAC) in AF trials. Key words: Atrial Fibrillation, Percutaneous Coronary Intervention, Triple …
[PDF][PDF] NOACs 用药教育对心房颤动患者抗凝认知水平的影响
李浩， 施芳红， 顾智淳， 沈珑， 张顺国， 刘晓琰 - 世界临床药物, 2019 - jwph.com.cn
… for non-vitamin K antagonist oral anticoagulant drugs (NOACs) in patients with atrial fibrillation,
… of blonanserin in healthy Chinese subjects[J]. Eur J Clin Pharmacol, 2018, 74(1): 61-67. …
… of blonanserin in healthy Chinese subjects[J]. Eur J Clin Pharmacol, 2018, 74(1): 61-67. …
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… 非瓣膜性心房颤动(nonvalvular atrial fibrillation, NVAF)是AF中… direct oral anticoagulants
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
(DOACs) over vitamin K antagonists … 非维生素K拮抗剂口服抗凝药物(non-vitamin K antagonist oral …
心房顫動患者使用新型口服抗凝血劑不同劑量之療效及安全性評估
李敏慈 - 國立臺灣大學流行病學與預防醫學研究所學位論文, 2020 - airitilibrary.com
… Non vitamin K antagonist oral anticoagulants (NOACs) … with non-valvular atrial
fibrillation(NVAF) to prevent stroke and … recommending NOAC dosage in Asia. Objectives The …
fibrillation(NVAF) to prevent stroke and … recommending NOAC dosage in Asia. Objectives The …
[PDF][PDF] 比較非維生素K 拮抗劑口服抗凝血劑與warfarin 在心房顫動和糖尿病患者中對糖尿病相關併發症及嚴重低血糖風險的影響
黃暉凱 - 2024 - tdr.lib.ntu.edu.tw
… non-vitamin K antagonist oral anticoagulants (NOACs) use and warfarin use due to their
varying effects on vitamin K function. … populations worldwide, atrial fibrillation has emerged as a …
varying effects on vitamin K function. … populations worldwide, atrial fibrillation has emerged as a …
心房颤动患者服用利伐沙班致出血的研究进展
姚娟 - Advances in Clinical Medicine, 2023 - hanspub.org
… Abstract: Atrial fibrillation is a common arrhythmia, the new oral anticoagulants (NOACs) …
, becomes the preferred treatment of patients with atrial fibrillation, the use of rivaroxaban is …
, becomes the preferred treatment of patients with atrial fibrillation, the use of rivaroxaban is …
[HTML][HTML] 慢性肾脏病患者口服抗凝药物临床应用的研究进展
杨富蓉， 钱懿轶， 周晓倩， 杨松烨， 陈韦兆… - Advances in Clinical …, 2023 - hanspub.org
… vitamin K antagonist warfarin and the introduction of new oral … of oral anticoagulants in patients
with CKD, aiming to provide … treatment decisions for patients with impaired renal function. …
with CKD, aiming to provide … treatment decisions for patients with impaired renal function. …
臨床療效及安全性之主動監測系統
林峰祺 - 2019 - tdr.lib.ntu.edu.tw
… in white people have AF and about 1% of adults in Asian countries. The … non-vitamin K
antagonist oral anticoagulants (NOACs) and warfarin in patients with non-valvular atrial fibrillation …
antagonist oral anticoagulants (NOACs) and warfarin in patients with non-valvular atrial fibrillation …